ALR Technologies IncOTCQB:ALRTF
- LAST PRICE0.0258
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0200/ 100
- Ask / Lots0.0240/ 200
- Open / Previous Close0.0000 / 0.0258
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | ALRTF |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ALR Technologies Inc | 14.8M | -1.8x | --- |
Bionoid Pharma Inc | 13.5M | 0.2x | --- |
BioSig Technologies Inc | 17.4M | -0.4x | --- |
Nexalin Technology Inc | 12.1M | -2.7x | --- |
QT Imaging Holdings Inc | 18.7M | -2.3x | --- |
Caduceus Software Systems Corp | 10.7M | -36.9x | --- |
Company Information
ALR Technologies Inc. is a data management company. The Company is engaged in the development of a comprehensive approach to diabetes care that includes a Food and Drug Administration (FDA) cleared diabetes management system (the Diabetes Solution), which collects data directly from blood glucose meters (BGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. The Company has developed the Diabetes Solution for human health, and the GluCurve, a modified version of the Diabetes Solution, for animal health (GluCurve) from its technology portfolio. The Company has developed its Diabetes Solution, which is a comprehensive approach to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring and diabetes test supplies. Its subsidiaries include ALR Technologies SG Pte. Ltd. and Canada Diabetes Solution Centre Inc.
Contact Information
- Headquarters
- Suite 300, 7400 Beaufont Springs DriveRICHMOND, VA, United States 23225
- Phone
- 804-554-3500
- Fax
- ---
Executives
- Chairman of the Board of Directors, Chief Executive Officer, Chief Financial Officer
- Soongling Chan
- Independent Director
- Ronald Cheng
- Independent Director
- Kenneth Robulak
- Independent Director
- Alfonso Salas
- Independent Director
- Peter Stafford
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.8M |
|---|---|
Revenue (TTM) | $9.5K |
Shares Outstanding | 571.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.31 |
EPS | $-0.01 |
Book Value | $-0.04 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 1,556.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39,032.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
